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INTRODUCTION
Brazilian spotted fever (BSF) is a rickettsial illness caused by 
the bacterium Rickettsia rickettsii(1). It is transmitted to humans 
by ticks, most commonly by the species Amblyomma sculptum 
(formerly Amblyomma cajennense), which is considered to be 
the main vector of the disease in Brazil(2).
Early diagnosis of BSF is often difficult, particularly during 
the first few days of the illness. The lack of specificity in its 
clinical signs results in low suspicion. The classical clinical 
marker, exanthema, is not always present, making appropriate 
medical conduct difficult(3). This difficulty leads to possible 
consequences, such as the use of inappropriate therapies and, 
as a result, a greater risk of severe cases and death(4). The main 
challenge is making a differential diagnosis relative to other 
more common and more widespread diseases, such as dengue 
fever and leptospirosis(5).
Fatal cases of Rickettsia rickettsii infection have thus far 
been reported inonly four Brazilian states, all of which are 
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increase in areas of transmission, it is considered to be the rickettsial illness of primary public health interest. Cases of this 
disease have historically occurred in Southeastern Brazil. This article reports the first fatal case of BSF in Southern Brazil. This 
case high lights the importance of BSF to be considered as a differential diagnosis for acute hemorrhagic fever in areas where 
cases of BSF may not be expected.
Keywords: Rickettsial illness. Rickettsia rickettsii. Tick-borne diseases.
located in the Southeastern region of the country: São Paulo(6), 
Minas Gerais(7), Rio de Janeiro(8), and Espírito Santo(9). The 
case-fatality rate has been found to range from 30% to 50%(5). 
Although infections caused by unknown spotted fever group 
agents of the genus Rickettsia have been reported in the Southern 
states of Brazil(1), there have been no confirmed cases or fatalities 
due to R. rickettsii. This report presents the first record of a 
human death caused by R. rickettsii in the Brazilian State of 
Paraná, located in the southern region of the country.
CASE REPORT
The patient was a 12-year-old girl from the City of 
São Carlos de Ivaí, located in the Northern part of Paraná State 
in Southern Brazil. On January 3, 2015, the patient presented 
with symptoms of hyporexia and weakness, followed by 
frontal headaches and a dry cough. She was medicated by 
family members with paracetamol, dipyrone, and diclofenac. 
On the seventh day, the patient presented with fever and 
abdominal pain. At this point, she sought medical attention. 
She was given paracetamol and discharged. On the ninth 
day of symptoms, the patient's condition worsened and she 
was hospitalized with suspected dengue fever based on her 
symptoms of fever, myalgia, headache, vomiting, exanthema, 
and dehydration. Tests to detect the NS1 antigen for dengue were 
negative, and blood tests revealed the presence of leukopenia 
and thrombocytopenia. During hospitalization, physicians 
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administered only symptomatic medication and parenteral 
hydration with crystalloids. On the 11th day, the patient presented 
with exanthema and a reduced level of consciousness, as well as 
psychomotor restlessness, anuria, worsened thrombocytopenia, 
and leukocytosis. Antibiotic therapy with ceftriaxone was 
initiated. The patient was transferred to the intensive care unit 
(ICU), where she had seizures. At this point, meningitis was 
suspected. The patient’s condition worsened, and hemodynamic 
and ventilatory support were initiated. These measures were 
provided by an ICU in a neighboring city, where the patient 
died on the 13th day of the illness. 
Laboratory investigations included immunologic and 
molecular analyses of a serum sample collected on January 14 
(the 11th day of the patient’s illness) for a diagnosis of spotted 
fever group rickettsiosis. An immunofluorescence antibody 
assay using R. ricketsii as the antigen yielded an immunoglobulin 
G (IgG) concentration of <64mg/dL and an immunoglobulin M 
(IgM) concentration of 128mg/dL. For a molecular analysis, 
a serum sample was submitted for deoxyribonucleic acid 
(DNA) extraction using the PureLink®Viral ribonucleic acid/
deoxyribonucleic acid (RNA/DNA) Mini Kit (Invitrogen, 
Carlsbad, CA, USA) and tested with two real-time polymerase 
chain reaction (PCR) assays: one targeting the rickettsial gltA 
gene of any member of the Rickettsia family(10), and another 
specific to R. rickettsii, targeting the hypothetical protein 
A1G_04230(11). Results of the patient’s serum DNA were 
positive for both assays. 
In an epidemiological investigation performed post-mortem, it 
was found that the patient had a history of travel to a farm with a 
lake inhabited by capybaras (Hydrochoerus hydrochaeris) within 
Ribeirão Claro municipality, Paraná State. During her last trip, 
she remained on the farm for 16 days. Her symptoms began the 
day after she returned. Because capybaras are considered to be 
the most important source of R. rickettsii infection to A. sculptum 
ticks in southeastern Brazil(1) (3), it is possible that BSF would have 
been suspected during the first days of illness had the information 
of the contact with capybaras been shared with the physicians. 
On the other hand, the physicians’ unfamiliarity with spotted 
fever rickettsiosis could also have contributed to the lack of BSF 
suspicious. Finally, the patient's city of residence (São Carlos do 
Ivaí) was experiencing a dengue fever epidemic at the time, which 
could have hampered the suspicious of other vector-borne diseases. 
DISCUSSION
Brazilian spotted fever has been considered one of the main 
challenges to public health in Brazil, particularly because of its 
high case-fatality rates. Factors that may be associated with the 
low rate of suspicion of BSF include health care professionals’ 
lack of knowledge on the clinical features of the disease, the 
eco-epidemic aspects associated with the risk of infection, and 
the risk factors for exposure to the vector and to the transmission 
areas of the disease(3).
The current case reflects the potential for the development 
of serious forms of the disease with systemic bodily 
dysfunction, such as respiratory and renal failure, hemorrhagic 
manifestations, neurological changes, and shock(5). This report 
also demonstrates that BSF frequently goes unrecognized as 
a diagnostic hypothesis and is frequently confused with more 
prevalent illnesses, such as leptospirosis, dengue fever, and 
meningococcal disease(3). In fact, the latter two were considered 
by physicians in the present case.
Dengue fever is the vector-borne disease with the most 
substantial impact in Brazil. Recent arbovirus events (which 
also cause febrile symptoms) represent a significant challenge 
when it comes to appropriate medical interventions in cases of 
BSF. The case in question is particularly noteworthy because of 
two factors that contributed to the outcome: 1) epidemiological 
history was not considered as part of the patient's clinical history 
during her treatment process, and so it was not determined 
that she had been in an area that was eco-epidemiologically 
associated with the risk of infection because it was a rural area 
inhabited by capybaras; and 2) no one considered the possibility 
that the infection developed in alocation different from the 
patient's city of residence that was endemic for the disease 
and where the patient traveled for leisure activities. If these 
possibilities had been considered during medical treatment, they 
would likely have contributed to a greater suspicion of BSF, 
making the use of appropriate antibiotic treatment more likely 
and, as a result, reducing the risk of death by BSF. 
Current treatment protocols for BSF include doxycycline, 
an antibiotic indicated for the treatment of R. rickettsii infection 
and other tick-borne diseases. Indeed, doxycycline is the first 
choice for treating clinical rickettsioses, regardless of a patient’s 
age(12). However, without more knowledge of the disease and 
the risk factors for infection, and considering the importance 
of introducing early adequate antibiotic treatment, it is unlikely 
that the treatment protocol will reduce case-fatality rates(3) (4) (5).
In conclusion, this report describes the first fatal case of BSF 
in a new endemic area of southern Brazil. The findings reflect 
the need for both early identification of new transmission areas 
and training for health care professionals to diagnose suspicious 
cases. This report therefore provides indispensable information 
to the search for methods to decrease deaths associated with 
BSF in Brazil. 
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